Global Point-of-Care Testing (POCT) Market Trends and Forecast To 2024

Report Code: HC-R-17-09DB - 7482 | Page Numbers: 0

Global Point-of-care Testing (POCT) Market Trends and Forecast to 2024 - By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World)...

Buy Now

"Get Notified On all out New and Upcoming Reports"

       on all the latest research reports

Global Point-of-care Testing (POCT) Market Trends and Forecast to 2024 - By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World)
1. Introduction
1.1. Overview of The Global Point-Of-Care Testing Market

1.2. Market Segmentation & Coverage

1.2.1. Currency and Pricing

1.2.2. Limitation

1.2.3. Stakeholders

2. Research Methodology
2.1. Key Takeaways

2.2. Arriving at The Global Point-Of-Care Testing Market Size

2.2.1. Market Crackdown Approach

2.2.2. Company Revenue and Market Share Analysis

2.2.3. Data Triangulation

2.2.4. Key Data Points from Primary Sources

2.2.5. Product Pipeline Analysis

2.2.6. Porter's Five Forces Matrix

2.3. Global Point-Of-Care Testing Market: Research Snapshot

2.4. Assumptions

3. Market Landscape Summary
4. Premium Insights
4.1. Overview

4.2. Global Point-Of-Care Testing Market: Key Primary Insights

4.3. Market Overview

4.3.1. Drivers

4.3.1.1. High Prevalence of Infectious Diseases in Developing Countries

4.3.1.2. Increasing Incidence of Lifestyle Diseases

4.3.1.3. Rising Usage of Home-Based Poc Devices

4.3.1.4. Growing Number of Regulatory Approvals For Novel Immunoassay Techniques

4.3.1.5. Shortage of Skilled Laboratory Technicians Increasing Preference of Poc Testing

4.3.1.6. Rising Incidence of Unplanned Preganancies

4.3.2. Restraints

4.3.3. Oppurtunities

4.3.4. Threats

4.4. Key Market Trends and Upcoming Technologies

5. Point-Of-Care Testing Market, By Type
5.1. Overview

5.2. Cardiometabolic Monitoring Kits, By Product Type

5.2.1. Cardiac Markers

5.2.2. Blood Gas Electrolyte Testing Kits

5.2.3. Hba1c Testing Kits

5.2.4. Lipid Testing Kits

5.3. Infectious Disease Testing Kits, By Product Type

5.3.1. Influenza Testing Kits

5.3.2. Hiv Testing Kits

5.3.3. Hepatitis C Testing Kits

5.3.4. Std Testing Kits

5.3.5. Tropical Disease Testing Kits

5.3.6. Healthcare Associated Infections Testing Kits

5.3.7. Respiratory Infections Testing Kits

5.3.8. Others

5.4. Cholestrol Testing Kits, By Product Type

5.4.1. Prothrombin Time Testing Kits

5.4.2. Activated Clotting Time Testing Kits

5.5. Blood Glucose Testing Kits

5.6. Pregnancy and Fertility Testing Kits

5.7. Tumor Cancer Markers

5.8. Urinalysis Testing Kits

5.9. Hematology Testing Kits

5.10. Drugs of Abuse Testing Kits

5.11. Fecal Occult Testing Kits

5.12. Rapid Coagulation Testing Kits

5.13. Others

6. Point-Of-Care Testing Market, By Prescription Mode
6.1. Overview

6.2. Prescription Based Testing Kits

6.3. Over the Counter (OTC) Based Testing Kits

7. Point-Of-Care Testing Market, By End-User
7.1. Overview

7.2. Hospitals

7.3. Clinics

7.4. Ambulatory Care

7.5. Home Healthcare

7.6. Research Laboratory

8. Point-Of-Care Testing Market, By Distribution Channel
8.1. Overview

8.2. Direct Tenders

8.3. Retail

9. Point-Of-Care Testing Market, By Geography

9.1. Countrywise Point of Care Testing Market, (All Segmentation Provided Above Is Represented In This Chapter By Country)

9.1.1. North America

9.1.1.1. U.S.

9.1.1.2. Canada

9.1.1.3. Mexico

9.1.2. Europe

9.1.2.1. Germany

9.1.2.2. France

9.1.2.3. U.K.

9.1.2.4. Italy

9.1.2.5. Spain

9.1.2.6. Russia

9.1.2.7. Turkey

9.1.2.8. Belgium

9.1.2.9. Netherlands

9.1.2.10. Switzerland

9.1.2.11. Rest of Europe

9.1.3. Asia-Pacific (Apac)

9.1.3.1. Japan

9.1.3.2. China

9.1.3.3. South Korea

9.1.3.4. India

9.1.3.5. Australia

9.1.3.6. Singapore

9.1.3.7. Thailand

9.1.3.8. Malaysia

9.1.3.9. Indonesia

9.1.3.10. Philippines

9.1.3.11. Rest of APAC

9.1.4. Latin America

9.1.4.1. Brazil

9.1.4.2. Rest of Latin America

9.1.5. Middle East and Africa

9.1.5.1. South Africa

9.1.5.2. Rest of Middle East and Africa

9.2. Key Primary Insights: By Major Countries

10. Point-Of-Care Testing Market: Competitive Landscape
10.1. Global Point of Care Testing Market: Company Share Analysis

10.2. U.S. Point of Care Testing Market: Company Share Analysis

10.3. Europe Point of Care Testing Market: Company Share Analysis

10.4. APAC Point of Care Testing Market: Company Share Analysis

10.5. South America Point of Care Testing Market: Company Share Analysis

10.6. Mea Point of Care Testing Market: Company Share Analysis

10.7. Mergers & Acquisitions

10.8. New Product Development & Approvals

10.9. Expansions

10.10. Regulatory Changes

10.11. Partnership and Other Strategic Developments

11. Point-Of-Care Testing Market: Company Profiles
11.1. Abbott Laboratories, Inc.

11.1.1 Company Overview

11.1.2 Swot Analysis

11.1.3 Revenue Analysis

11.1.4 Product Portfolio

11.1.5 Recent Developements

11.1.6 Data Bridge Analysis

11.2. Roche Diagnostics Limited

11.2.1 Company Overview

11.2.2 Swot Analysis

11.2.3 Revenue Analysis

11.2.4 Product Portfolio

11.2.5 Recent Developements

11.2.6 Data Bridge Analysis

11.3. Siemens Ag

11.3.1 Company Overview

11.3.2 Swot Analysis

11.3.3 Revenue Analysis

11.3.4 Product Portfolio

11.3.5 Recent Developements

11.3.6 Data Bridge Analysis

11.4. Beckman Coulter, Inc.

11.4.1 Company Overview

11.4.2 Swot Analysis

11.4.3 Revenue Analysis

11.4.4 Product Portfolio

11.4.5 Recent Developements

11.4.6 Data Bridge Analysis

11.5. Becton, Dickinson And Company

11.5.1 Company Overview

11.5.2 Swot Analysis

11.5.3 Revenue Analysis

11.5.4 Product Portfolio

11.5.5 Recent Developements

11.5.6 Data Bridge Analysis

11.6. Johnson & Johnson

11.6.1 Company Overview

11.6.2 Swot Analysis

11.6.3 Revenue Analysis

11.6.4 Product Portfolio

11.6.5 Recent Developements

11.6.6 Data Bridge Analysis

11.7. Alere Inc.

11.7.1 Company Overview

11.7.2 Swot Analysis

11.7.3 Revenue Analysis

11.7.4 Product Portfolio

11.7.5 Recent Developements

11.7.6 Data Bridge Analysis

11.8. Instrumentation Laboratory

11.8.1 Company Overview

11.8.2 Swot Analysis

11.8.3 Revenue Analysis

11.8.4 Product Portfolio

11.8.5 Recent Developements

11.8.6 Data Bridge Analysis

11.9. Pts Diagnostics

11.9.1 Company Overview

11.9.2 Swot Analysis

11.9.3 Revenue Analysis

11.9.4 Product Portfolio

11.9.5 Recent Developements

11.9.6 Data Bridge Analysis

11.10. Abaxis, Inc.

11.10.1 Company Overview

11.10.2 Swot Analysis

11.10.3 Revenue Analysis

11.10.4 Product Portfolio

11.10.5 Recent Developements

11.10.6 Data Bridge Analysis

11.11. Medtronic

11.11.1 Company Overview

11.11.2 Swot Analysis

11.11.3 Revenue Analysis

11.11.4 Product Portfolio

11.11.5 Recent Developements

11.11.6 Data Bridge Analysis

11.12. Accriva Diagnostics

11.12.1 Company Overview

11.12.2 Swot Analysis

11.12.3 Revenue Analysis

11.12.4 Product Portfolio

11.12.5 Recent Developements

11.12.6 Data Bridge Analysis

11.13. Opti Medical

11.13.1 Company Overview

11.13.2 Swot Analysis

11.13.3 Revenue Analysis

11.13.4 Product Portfolio

11.13.5 Recent Developements

11.13.5 Data Bridge Analysis

11.14. Sienco, Inc.

11.14.1 Company Overview

11.14.2 Swot Analysis

11.14.3 Revenue Analysis

11.14.4 Product Portfolio

11.14.5 Recent Developements

11.14.6 Data Bridge Analysis

11.15. Alpha Scientific

11.15.1 Company Overview

11.15.2 Swot Analysis

11.15.3 Revenue Analysis

11.15.4 Product Portfolio

11.15.5 Recent Developements

11.15.6 Data Bridge Analysis

11.16. Accubiotech Co. Ltd.

11.16.1 Company Overview

11.16.2 Swot Analysis

11.16.3 Revenue Analysis

11.16.4 Product Portfolio

11.16.5 Recent Developements

11.16.5 Data Bridge Analysis

11.17. Acon Laboratories, Inc.

11.17.1 Company Overview

11.17.2 Swot Analysis

11.17.3 Revenue Analysis

11.17.4 Product Portfolio

11.17.5 Recent Developements

11.17.6 Data Bridge Analysis

11.18. Acrongenomics

11.18.1 Company Overview

11.18.2 Swot Analysis

11.18.3 Revenue Analysis

11.18.4 Product Portfolio

11.18.5 Recent Developements

11.18.6 Data Bridge Analysis

11.19. Biom?rieux, Biomerica, Inc.

11.19.1 Company Overview

11.19.2 Swot Analysis

11.19.3 Revenue Analysis

11.19.4 Product Portfolio

11.19.5 Recent Developements

11.19.6 Data Bridge Analysis

11.20. Atlas Genetics Ltd.

11.20.1 Company Overview

11.20.2 Swot Analysis

11.20.3 Revenue Analysis

11.20.4 Product Portfolio

11.20.5 Recent Developements

11.20.6 Data Bridge Analysis

11.21. Alfa Scientific Designs, Inc.

11.21.1 Company Overview

11.21.2 Swot Analysis

11.21.3 Revenue Analysis

11.21.4 Product Portfolio

11.21.5 Recent Developements

11.21.6 Data Bridge Analysis

11.22. Bio-Rad Laboratories, Inc.

11.22.1 Company Overview

11.22.2 Swot Analysis

11.22.3 Revenue Analysis

11.22.4 Product Portfolio

11.22.5 Recent Developements

11.22.6 Data Bridge Analysis

11.23. Medica Corporation

11.23.1 Company Overview

11.23.2 Swot Analysis

11.23.3 Revenue Analysis

11.23.4 Product Portfolio

11.23.5 Recent Developements

11.23.6 Data Bridge Analysis

11.24. Nova Biomedical

11.24.1 Company Overview

11.24.2 Swot Analysis

11.24.3 Revenue Analysis

11.24.4 Product Portfolio

11.24.5 Recent Developements

11.24.6 Data Bridge Analysis

12. Appendix
12.1. Sources and Bibliography

12.2. Related Reports

12.3. A Glimse Of Data Bridge Market Research Factbook

13. About Data Bridge Market Research
Synopsis:


Global point-of-care testing market is expected to reach USD 38.2 billion by 2024, at a CAGR of 9.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.


Point of care testing (POCT) helps in the rapid performance of diagnostic tests despite patient being at the point of care facility. This helps in obtaining the results immediately rather than waiting for hours or even days outside the laboratory. POCT has become significant part of patient care at various health care facilities. Point-of-care testing includes glucometer, lipid analysers, coagulation analysers, and hematology analysers among others. These tests are planned so that they can be used near the site of patients' location which does not require permanent space and can be performed in non-laboratory settings such as in the physician's office, ambulance, home, field, and hospital.


The Global Point-Of- Care Testing Market has been segmented On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.


Based on prescription mode, the global point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.


On the basis of distribution channel, the market is segmented into direct tenders and retail.
Based on end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.


The global point-of-care testing market is segmented into geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. These regions are further classified on the basis of country, into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.


Major Players Operating in this market:

Abbott Laboratories, Inc., Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, bioM?rieux, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedical.
Regions Covered in The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America),Rest of World)).

Download Sample

Just fill the short form below to get the sample

Don’t like forms? Give us a call. U.S. +1(973)805-7440 (International) Email us at: amit@ceskaa.com